Petition for Inter Partes Review by Obalon Therapeutics, Inc.

On March 3, 2017, Obalon Therapeutics, Inc. (“Petitioner”) filed a Petition to the USPTO’s Patent Trial and Appeal Board (“Board”) for an inter partes review of claims 1-18 of U.S. Patent No. 6,712,832 (“the ‘832 Patent”).  The ‘832 Patent, which is owned by Tilak M. Shah, is directed to low pressure medical balloons for various medical procedures.  In the Petition, Petitioner asserts that claims 1-18 of the ‘832 Patent are anticipated and/or obvious under 35 U.S.C. §§ 102 and/or 103 over various patent documents.  The inter partes review remains pending at the Board and is captioned IPR2017-01023.

By:  Jacqueline A. DiRamio

View Attachment (PDF)